Cargando…
Exercise during chemotherapy: Friend or foe?
BACKGROUND: A higher chemotherapy completion rate is associated with better outcomes including treatment efficacy and overall survival. Exercise may have the potential to improve relative dose intensity (RDI) by reducing the frequency and severity of chemotherapy‐related toxicities. We examined the...
Autores principales: | Potiaumpai, Melanie, Schleicher, Erica A., Wang, Ming, Campbell, Kristin L., Sturgeon, Kathleen, Schmitz, Kathryn H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225227/ https://www.ncbi.nlm.nih.gov/pubmed/37076972 http://dx.doi.org/10.1002/cam4.5831 |
Ejemplares similares
-
Cost evaluation of an exercise oncology intervention: The exercise in all chemotherapy trial
por: Potiaumpai, Melanie, et al.
Publicado: (2021) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
Exercise-induced oxidative stress: Friend or foe?
por: Powers, Scott K., et al.
Publicado: (2020) -
Commentary: Exercise and Intraocular Pressure: Friends or foes?
por: Kumar, Harsh, et al.
Publicado: (2022) -
Friend and Foe
Publicado: (1890)